Dr. Martens (DOCS) Trading Update summary

Trading performance and outlook

• Trading since the start of the financial year has met expectations, with FY26 guidance unchanged.

• Americas Direct to Consumer channel showed positive momentum, especially in retail and full-price sales.

• EMEA DTC business remains variable, with the UK market facing ongoing challenges.

• APAC region continues to grow, led by strong performance in South Korea's shoes category.

• Autumn/Winter order books are healthy globally; EMEA order book is up year-on-year, Americas is stable with a broader product range.

Strategic initiatives and future focus

• Focus remains on embedding the new consumer-first Levers for Growth strategy introduced in June.

• Strategy aims to engage more consumers, increase purchase occasions, optimize distribution, and simplify operations.

• Performance is expected to be weighted towards the second half of the year, especially for profit.

• Early progress on strategic initiatives will be detailed at the first half results in November.